Drug Shortage Report for CEFUROXIME FOR INJECTION, USP

Last updated on 2020-08-13 History
Report ID 122225
Drug Identification Number 02422328
Brand name CEFUROXIME FOR INJECTION, USP
Common or Proper name CEFUROXIME FOR INJECTION, USP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) CEFUROXIME
Strength(s) 7.5G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 VIALS
ATC code J01DC
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2020-07-31
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2020-08-13
Company comments BUSINESS REASONS.
Health Canada comments
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-08-13 French Compare
v1 2020-08-13 English Compare